Preprocedural Lp(a) level and ApoB/ApoA-Ι ratio and the risk for contrast-induced acute kidney injury in patients undergoing emergency PCI

被引:2
作者
Tao, Jun [1 ]
Dai, Wen [1 ]
Ye, Chenglin [2 ]
Yao, Qian [1 ]
Zhou, Man [1 ]
Li, Yan [1 ]
机构
[1] Wuhan Univ, Renmin Hosp, Dept Clin Lab, Jiefang Rd 238, Wuhan 430060, Hubei, Peoples R China
[2] Wuhan Univ, Renmin Hosp, Dept Urol, Wuhan, Peoples R China
基金
中国国家自然科学基金;
关键词
Lipoprotein(a) level; ApoB/ApoA-I ratio; Contrast-induced acute kidney injury; LIPOPROTEIN(A); CHOLESTEROL; LDL; APOLIPOPROTEIN(A); INFLAMMATION; NEPHROPATHY; METABOLISM; DISEASE;
D O I
10.1186/s12944-021-01535-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background High serum Lipoprotein(a) (Lp(a)) level and Apolipoprotein B/Apolipoprotein A Iota (ApoB/ApoA-Iota) ratio are risk factors for cardiovascular disease and kidney disease and have been found to be correlated with the prevalence and prognosis of various kidney diseases. However, it is not clear whether the serum Lp(a) level and ApoB/ApoA-Iota ratio pre-PCI are correlated with the prevalence of contrast-induced acute kidney injury (CI-AKI). Methods A total of 931 participants undergoing emergency PCI from July 2018 to July 2020 were included. According to whether the serum creatinine concentration was higher than the baseline concentration (by >= 25% or >= 0.5 mg/dL) 48-72 h after contrast exposure, these participants were divided into a CI-AKI group (n = 174) and a non-CI-AKI group (n = 757). Serum Lp(a), ApoA-Iota and ApoB concentration were detected in the patients when they were admitted to hospital, and the ApoB/ApoA-Iota ratio was calculated. Logistic regression and restricted cubic spline analyses were used to explore the correlation between the Lp(a) concentration or the ApoB/ApoA-Iota ratio and the risk of CI-AKI. Results Among the 931 participants undergoing emergency PCI, 174 (18.69%) participants developed CI-AKI. Compared with the non-CI-AKI group, the Lp(a) level and ApoB/ApoA-Iota ratio pre-PCI in the CI-AKI group were significantly higher (P < 0.05). The incidence of CI-AKI was positively associated with the serum Lp(a) level and ApoB/ApoA-Iota ratio pre-PCI in each logistic regression model (P < 0.05). After adjusting for all the risk factors included in this study, restricted cubic spline analyses found that the Lp(a) level and the ApoB/ApoA-Iota ratio before PCI, within certain ranges, were positively associated with the prevalence of CI-AKI. Conclusion High Lp(a) levels and high ApoB/ApoA-Iota ratios before PCI are potential risk factors for CI-AKI.
引用
收藏
页数:8
相关论文
共 40 条
  • [1] Radial vs femoral access for the prevention of acute kidney injury (AKI) after coronary angiography or intervention: A systematic review and meta-analysis
    Ando, Giuseppe
    Gragnano, Felice
    Calabro, Paolo
    Valgimigli, Marco
    [J]. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2018, 92 (07) : E518 - E526
  • [2] Lipoprotein(a): a genetic marker for cardiovascular disease and target for emerging therapies
    Cesaro, Arturo
    Schiavo, Alessandra
    Moscarella, Elisabetta
    Coletta, Silvio
    Conte, Matteo
    Gragnano, Felice
    Fimiani, Fabio
    Monda, Emanuele
    Caiazza, Martina
    Limongelli, Giuseppe
    D'Erasmo, Laura
    Riccio, Carmine
    Arca, Marcello
    Calabro, Paolo
    [J]. JOURNAL OF CARDIOVASCULAR MEDICINE, 2021, 22 (03) : 151 - 161
  • [3] Contrast-Induced Acute Kidney Injury: An Update
    Chalikias, George
    Drosos, Ioannis
    Tziakas, Dimitrios N.
    [J]. CARDIOVASCULAR DRUGS AND THERAPY, 2016, 30 (02) : 215 - 228
  • [4] Genetic Variants Associated with Lp(a) Lipoprotein Level and Coronary Disease
    Clarke, Robert
    Peden, John F.
    Hopewell, Jemma C.
    Kyriakou, Theodosios
    Goel, Anuj
    Heath, Simon C.
    Parish, Sarah
    Barlera, Simona
    Franzosi, Maria Grazia
    Rust, Stephan
    Bennett, Derrick
    Silveira, Angela
    Malarstig, Anders
    Green, Fiona R.
    Lathrop, Mark
    Gigante, Bruna
    Leander, Karin
    de Faire, Ulf
    Seedorf, Udo
    Hamsten, Anders
    Collins, Rory
    Watkins, Hugh
    Farrall, Martin
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (26) : 2518 - 2528
  • [5] De Sain-Van der Velden MGM, 1998, J AM SOC NEPHROL, V9, P1474
  • [6] ELEVATED LIPOPROTEIN-(A) LEVELS IN PRIMARY NEPHROTIC SYNDROME
    FAUCHER, C
    DOUCET, C
    BAUMELOU, A
    CHAPMAN, J
    JACOBS, C
    THILLET, J
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1993, 22 (06) : 808 - 813
  • [7] Impact of lipoprotein(a) levels on recurrent cardiovascular events in patients with premature coronary artery disease
    Gragnano, Felice
    Fimiani, Fabio
    Di Maio, Marco
    Cesaro, Arturo
    Limongelli, Giuseppe
    Cattano, Davide
    Calabro, Paolo
    [J]. INTERNAL AND EMERGENCY MEDICINE, 2019, 14 (04) : 621 - 625
  • [8] Lipoprotein(a) induces glomerular superoxide anion production
    Greiber, S
    Kreusel, M
    Pavenstadt, H
    Schollmeyer, P
    Wanner, C
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 1997, 12 (07) : 1330 - 1335
  • [9] Effects of lipoprotein(a) on mesangial cell proliferation and viability
    Greiber, S
    KramerGuth, A
    Pavenstadt, H
    Gutenkunst, M
    Schollmeyer, P
    Wanner, C
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 1996, 11 (05) : 778 - 785
  • [10] Short-Term Rosuvastatin Therapy for Prevention of Contrast-Induced Acute Kidney Injury in Patients With Diabetes and Chronic Kidney Disease
    Han, Yaling
    Zhu, Guoying
    Han, Lixian
    Hou, Fengxia
    Huang, Weijian
    Liu, Huiliang
    Gan, Jihong
    Jiang, Tiemin
    Li, Xiaoyan
    Wang, Wei
    Ding, Shifang
    Jia, Shaobin
    Shen, Weifeng
    Wang, Dongmei
    Sun, Ling
    Qiu, Jian
    Wang, Xiaozeng
    Li, Yi
    Deng, Jie
    Li, Jing
    Xu, Kai
    Xu, Bo
    Mehran, Roxana
    Huo, Yong
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (01) : 62 - 70